Editor's note: This is the fifth article in a series on investing in China. The previous columns were Four Ways to Play China, China Investing: Like a Kid in a Toy Store, How (Not) to Invest in China and Catching China's Uplisting Wave.
My grandfather is a berry-picking legend where I come from. The rate at which he picked seems to accelerate as the story propagates, but I would like to show how you can apply successful wild berry-picking principles to stock picking.
Right now, the picking is good in Chinese pharmaceuticals. If you know what you're doing I believe you can turn thousands into millions over the next couple years. And that's after taxes.
1. You need to know where to look.If you go looking for berries in the desert, you might be disappointed. If you're looking for pharmaceuticals, you might run across Lotus Pharmaceuticals (LTUS.OB). Like Jack's magical beanstalk berry, Lotus is my red pill from the "Matrix" and it's only up 78% since I mentioned it in May. Although Lotus hasn't taken real steps to uplist and the stock price has had a negative correlation with company performance, it is my belief that not picking up this stock is shortsighted to the highest degree. In June it was again awarded Good Supply Practices certification. If you are shortsighted you'll never make ends meet berry picking and you'll never find a company like Lotus that is growing and trading at less than twice earnings. 2. You need to know when to look. Although China has been running headlines and a lot of people are bubbling with excitement it was only last year when China was the poison berry. When you buy determines the price you pay and, therefore, the risk you undertake as I believe risk comes only from overpaying.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV